Voloridge Investment Management
AMAG

Voloridge Investment Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Voloridge Investment Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,318
Closed -$126K – 1531
2019
Q4 		$126K Buy
+10,318
New +$113K ﹤0.01% 1029
2019
Q2 		– Sell
-38,870
Closed -$501K – 1211
2019
Q1 		$501K Buy
+38,870
New +$579K 0.02% 669
2017
Q1 		– Sell
-101,290
Closed -$3.52M – 755
2016
Q4 		$3.52M Buy
+101,290
New +$3.03M 0.08% 313
2016
Q2 		– Sell
-14,126
Closed -$331K – 436
2016
Q1 		$331K Buy
+14,126
New +$335K 0.01% 286
2015
Q4 		– Sell
-201,549
Closed -$8.01M – 345
2015
Q3 		$8.01M Buy
201,549
+193,154
+2,301% +$12M 0.38% 67
2015
Q2 		$580K Sell
8,395
-19,562
-70% -$1.23M 0.03% 253
2015
Q1 		$1.53M Buy
+27,957
New +$1.33M 0.07% 201

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Voloridge Investment Management's AMAG Position: Q1 2020 in Review

Voloridge Investment Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2020, closing a stake of 10,318 shares — an estimated $126K sold.

Voloridge Investment Management first reported a position in AMAG in Q1 2015 and held it in 7 quarters. The position peaked at $8.01M in Q3 2015. 119 funds tracked by Wall St. Rank hold AMAG as of Q1 2020.

  • Voloridge Investment Management reported no remaining AMAG Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Voloridge Investment Management sold 10,318 AMAG Pharmaceuticals shares in Q1 2020, an estimated $126K.
  • Voloridge Investment Management first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 7 quarters.
  • Voloridge Investment Management's AMAG Pharmaceuticals position peaked at $8.01M in Q3 2015.
  • 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2020.

Based on Voloridge Investment Management's 13F filing for Q1 2020, filed 15 May 2020.